HIF-2α deficiency likely explains why chronic kidney disease is accompanied by anemia and blunted production of erythropoietin, as well as why impaired erythropoietin synthesis is accompanied by increased inflammatory and angiogenic markers. Here, EPO is linked to chronic kidney disease.